Clinical Trials on 甲状腺激素抵抗综合症 in Germany
总计220个结果
-
Ruhr University of BochumWissenschaftskommission des Universitaetsklinikums Bergmannsheil; Private Sponsor (Chantal C...未知
-
Jena University HospitalGE Healthcare未知
-
University of WuerzburgDeutsche Krebshilfe e.V., Bonn (Germany)招聘中
-
University Hospital MuensterNichols Institute Diagnostika GmbH, Bad Vilbel, Germany完全的
-
University Hospital TuebingenMerck Sharp & Dohme LLC撤销
-
Genzyme, a Sanofi Company完全的
-
University Hospital MuensterDeutsche Krebshilfe e.V., Bonn (Germany)完全的
-
Charite University, Berlin, GermanyKlinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Bonn AöR招聘中
-
Slimbiotics GmbHClinical Research Center Kiel GmbH完全的
-
German Institute of Human NutritionBeneo GmbH完全的
-
Hannover Medical School完全的
-
German Institute of Human NutritionUniversity Hospital Tuebingen; Ernst von Bergmann Hospital; Ministry of Food and Agriculture,... 和其他合作者完全的
-
University of HohenheimGerman Federal Ministry of Education and Research完全的
-
Paola Anna ErbaErasmus Medical Center; Jagiellonian University; Medical University Innsbruck; University Hospital... 和其他合作者完全的
-
Hannover Medical School完全的
-
Technical University of MunichGerman Federal Ministry of Education and Research完全的
-
German Institute of Human NutritionCharite University, Berlin, Germany; University Hospital Tuebingen; Ernst von Bergmann Hospital; German Diabetes Foundation, Munich, Germany完全的
-
Asklepios proresearchUniversitätsklinikum Hamburg-Eppendorf; City of Hamburg完全的
-
AstraZeneca终止
-
Genzyme, a Sanofi CompanyWorldwide Clinical Trials完全的有症状的、侵袭性的、散发的、不可切除的、局部的 | 晚期/转移性甲状腺髓样癌 (MTC)比利时, 意大利, 荷兰, 西班牙, 法国, 德国, 英国, 卢森堡
-
University of Erlangen-Nürnberg Medical School未知
-
Stoffwechselzentrum Rhein - PfalzGlucanova AB完全的